Free Trial

Zepp Health (ZEPP) Competitors

Zepp Health logo
$6.14 -0.33 (-5.03%)
Closing price 06/5/2026 03:58 PM Eastern
Extended Trading
$6.28 +0.15 (+2.36%)
As of 06/5/2026 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ZEPP vs. OSS, ALLT, LTRX, SILC, and RDCM

Should you buy Zepp Health stock or one of its competitors? MarketBeat compares Zepp Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zepp Health include One Stop Systems (OSS), Allot (ALLT), Lantronix (LTRX), Silicom (SILC), and Radcom (RDCM). These companies are all part of the "computer hardware" industry.

How does Zepp Health compare to One Stop Systems?

One Stop Systems (NASDAQ:OSS) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

One Stop Systems has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than One Stop Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
One Stop Systems$32.22M12.97$5.09M$0.2567.56
Zepp Health$258.90M0.35-$40.07M-$2.51N/A

32.7% of One Stop Systems shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 3.9% of One Stop Systems shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, One Stop Systems had 2 more articles in the media than Zepp Health. MarketBeat recorded 3 mentions for One Stop Systems and 1 mentions for Zepp Health. One Stop Systems' average media sentiment score of 0.42 beat Zepp Health's score of 0.00 indicating that One Stop Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
One Stop Systems
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Zepp Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

One Stop Systems has a net margin of 12.44% compared to Zepp Health's net margin of -15.48%. One Stop Systems' return on equity of -0.24% beat Zepp Health's return on equity.

Company Net Margins Return on Equity Return on Assets
One Stop Systems12.44% -0.24% -0.18%
Zepp Health -15.48%-15.00%-6.07%

One Stop Systems currently has a consensus target price of $16.00, indicating a potential downside of 5.27%. Zepp Health has a consensus target price of $56.28, indicating a potential upside of 817.36%. Given Zepp Health's higher probable upside, analysts clearly believe Zepp Health is more favorable than One Stop Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
One Stop Systems
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Zepp Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

One Stop Systems has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, indicating that its share price is 78% more volatile than the broader market.

Summary

One Stop Systems beats Zepp Health on 11 of the 16 factors compared between the two stocks.

How does Zepp Health compare to Allot?

Allot (NASDAQ:ALLT) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

Allot has a net margin of 5.68% compared to Zepp Health's net margin of -15.48%. Allot's return on equity of 7.38% beat Zepp Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Allot5.68% 7.38% 4.70%
Zepp Health -15.48%-15.00%-6.07%

Allot has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, meaning that its stock price is 78% more volatile than the broader market.

51.5% of Allot shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 3.4% of Allot shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Allot has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Allot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allot$101.99M3.53$3.70M$0.1356.85
Zepp Health$258.90M0.35-$40.07M-$2.51N/A

In the previous week, Allot had 3 more articles in the media than Zepp Health. MarketBeat recorded 4 mentions for Allot and 1 mentions for Zepp Health. Allot's average media sentiment score of 0.17 beat Zepp Health's score of 0.00 indicating that Allot is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Allot
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Zepp Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Allot currently has a consensus target price of $13.63, suggesting a potential upside of 84.37%. Zepp Health has a consensus target price of $56.28, suggesting a potential upside of 817.36%. Given Zepp Health's higher probable upside, analysts clearly believe Zepp Health is more favorable than Allot.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allot
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Zepp Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Allot beats Zepp Health on 11 of the 16 factors compared between the two stocks.

How does Zepp Health compare to Lantronix?

Zepp Health (NYSE:ZEPP) and Lantronix (NASDAQ:LTRX) are both small-cap computer hardware companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Lantronix had 1 more articles in the media than Zepp Health. MarketBeat recorded 2 mentions for Lantronix and 1 mentions for Zepp Health. Lantronix's average media sentiment score of 0.25 beat Zepp Health's score of 0.00 indicating that Lantronix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zepp Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Lantronix
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Zepp Health has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market. Comparatively, Lantronix has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market.

52.6% of Zepp Health shares are held by institutional investors. Comparatively, 39.4% of Lantronix shares are held by institutional investors. 36.0% of Zepp Health shares are held by insiders. Comparatively, 2.4% of Lantronix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Zepp Health currently has a consensus target price of $56.28, suggesting a potential upside of 817.36%. Lantronix has a consensus target price of $8.83, suggesting a potential upside of 34.65%. Given Zepp Health's higher probable upside, analysts clearly believe Zepp Health is more favorable than Lantronix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zepp Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Lantronix
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Lantronix has a net margin of -5.52% compared to Zepp Health's net margin of -15.48%. Lantronix's return on equity of -6.79% beat Zepp Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Zepp Health-15.48% -15.00% -6.07%
Lantronix -5.52%-6.79%-4.17%

Lantronix has lower revenue, but higher earnings than Zepp Health. Lantronix is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zepp Health$258.90M0.35-$40.07M-$2.51N/A
Lantronix$122.92M2.35-$11.37M-$0.17N/A

Summary

Lantronix beats Zepp Health on 10 of the 16 factors compared between the two stocks.

How does Zepp Health compare to Silicom?

Silicom (NASDAQ:SILC) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

Silicom has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, suggesting that its stock price is 78% more volatile than the broader market.

Zepp Health has a net margin of -15.48% compared to Silicom's net margin of -16.57%. Silicom's return on equity of -9.30% beat Zepp Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Silicom-16.57% -9.30% -7.24%
Zepp Health -15.48%-15.00%-6.07%

In the previous week, Silicom and Silicom both had 1 articles in the media. Silicom's average media sentiment score of 0.95 beat Zepp Health's score of 0.00 indicating that Silicom is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Silicom
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zepp Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Silicom has higher earnings, but lower revenue than Zepp Health. Silicom is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Silicom$61.93M3.51-$11.48M-$1.93N/A
Zepp Health$258.90M0.35-$40.07M-$2.51N/A

52.9% of Silicom shares are held by institutional investors. Comparatively, 52.6% of Zepp Health shares are held by institutional investors. 25.4% of Silicom shares are held by insiders. Comparatively, 36.0% of Zepp Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Zepp Health has a consensus target price of $56.28, suggesting a potential upside of 817.36%. Given Zepp Health's stronger consensus rating and higher possible upside, analysts plainly believe Zepp Health is more favorable than Silicom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Silicom
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Zepp Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Zepp Health beats Silicom on 9 of the 15 factors compared between the two stocks.

How does Zepp Health compare to Radcom?

Radcom (NASDAQ:RDCM) and Zepp Health (NYSE:ZEPP) are both small-cap computer hardware companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Radcom has a net margin of 17.18% compared to Zepp Health's net margin of -15.48%. Radcom's return on equity of 11.68% beat Zepp Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Radcom17.18% 11.68% 9.16%
Zepp Health -15.48%-15.00%-6.07%

In the previous week, Zepp Health had 1 more articles in the media than Radcom. MarketBeat recorded 1 mentions for Zepp Health and 0 mentions for Radcom. Radcom's average media sentiment score of 0.00 equaled Zepp Health'saverage media sentiment score.

Company Overall Sentiment
Radcom Neutral
Zepp Health Neutral

Radcom currently has a consensus target price of $18.00, suggesting a potential upside of 46.10%. Zepp Health has a consensus target price of $56.28, suggesting a potential upside of 817.36%. Given Zepp Health's higher probable upside, analysts clearly believe Zepp Health is more favorable than Radcom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Radcom
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Zepp Health
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Radcom has higher earnings, but lower revenue than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Radcom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Radcom$71.49M2.88$11.99M$0.7516.43
Zepp Health$258.90M0.35-$40.07M-$2.51N/A

48.3% of Radcom shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 69.0% of Radcom shares are owned by insiders. Comparatively, 36.0% of Zepp Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Radcom has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market. Comparatively, Zepp Health has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market.

Summary

Radcom beats Zepp Health on 9 of the 14 factors compared between the two stocks.

Get Zepp Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZEPP vs. The Competition

MetricZepp HealthMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$90.87M$1.53B$6.68B$23.06B
Dividend YieldN/AN/A2.67%4.10%
P/E Ratio-2.4478.1924.0330.25
Price / Sales0.357.19519.3322.11
Price / CashN/A22.8942.2323.97
Price / Book0.424.779.734.63
Net Income-$40.07M-$54.76M$3.57B$1.07B
7 Day Performance-25.19%-2.69%-1.26%-1.66%
1 Month Performance-66.09%5.96%0.82%-1.68%
1 Year Performance155.09%-5.16%24.09%21.33%

Zepp Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZEPP
Zepp Health
2.7837 of 5 stars
$6.14
-5.0%
$56.28
+817.4%
+147.4%$90.87M$258.90MN/A1,230
OSS
One Stop Systems
1.392 of 5 stars
$17.49
-1.9%
$13.00
-25.7%
+450.2%$432.70M$32.22M69.96110
ALLT
Allot
4.3331 of 5 stars
$7.61
-1.2%
$13.63
+79.0%
-15.3%$370.23M$101.99M58.54740
LTRX
Lantronix
2.8085 of 5 stars
$7.01
-1.0%
$8.83
+26.0%
+182.8%$279.14M$122.92MN/A350
SILC
Silicom
0.6593 of 5 stars
$46.11
+1.7%
N/A+160.3%$263.10M$66.64MN/A320

Related Companies and Tools


This page (NYSE:ZEPP) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners